HLA-E structures
26 items
Page 1 of 2 | 25 items per page | ordered by release date, descending
1 27P4B |
HLA-E*01:03 binding "IMYNYPAML" at 1.72Å resolution |
7P49 |
HLA-E*01:03 binding "RMAATAQVL" at 2.05Å resolution |
7BH8 |
HLA-E*01:03 binding "VMAPRTVLL" with antibody at 1.80Å resolution |
7NDU |
HLA-E*01:03 presenting "RMYSPVSIL" to Alpha/Beta T cell receptor at 2.90Å resolution |
6ZKZ |
HLA-E*01:03 presenting "RLPAKAPL" to Alpha/Beta T cell receptor at 2.30Å resolution |
6ZKY |
HLA-E*01:03 presenting "RLPAKAPL" to Alpha/Beta T cell receptor at 2.65Å resolution |
7NDT |
HLA-E*01:03 presenting "VMAPRTLIL" to Alpha/Beta T cell receptor at 3.00Å resolution |
7NDQ |
HLA-E*01:03 presenting "RMYSPVSIL" to Alpha/Beta T cell receptor at 2.55Å resolution |
6ZKX |
HLA-E*01:03 presenting "RLPAKAPLLGCG" to Alpha/Beta T cell receptor at 2.17Å resolution |
6ZKW |
HLA-E*01:03 presenting "RLPAKAPLL" to Alpha/Beta T cell receptor at 2.26Å resolution |
6GH1 |
HLA-E*01:03 binding "RLPAKAPLL" at 2.10Å resolution |
6GGM |
HLA-E*01:03 binding "RFPAKAPLL" at 2.73Å resolution |
6GHN |
HLA-E*01:03 binding "RLPAKAPLF" at 2.54Å resolution |
6GH4 |
HLA-E*01:03 binding "RQPAKAPLL" at 2.16Å resolution |
6GL1 |
HLA-E*01:03 binding "RMYSPTSIL" at 2.62Å resolution |
5W1V |
HLA-E*01:01 presenting "VMAPRTLIL" to Alpha/Beta T cell receptor at 3.31Å resolution |
5W1W |
HLA-E*01:01 presenting "VMAPRTLVL" to Alpha/Beta T cell receptor at 3.10Å resolution |
3AM8 |
HLA-E*01:01 binding "VMGPRTLIL" at 2.80Å resolution |
3CII |
HLA-E*01:01 binding "VMAPRTLFL" with CD94 and NKG2A at 4.41Å resolution |
3BZF |
HLA-E*01:01 binding "VMAPRALLL" at 2.50Å resolution |
3BZE |
HLA-E*01:01 binding "VMAPRTLFL" at 2.50Å resolution |
3CDG |
HLA-E*01:01 binding "VMAPRTLFL" with CD94 and NKG2A at 3.40Å resolution |
2ESV |
HLA-E*01:01 presenting "VMAPRTLIL" to Alpha/Beta T cell receptor at 2.60Å resolution |
1KPR |
HLA-E*01:03 binding "VMAPRTVLL" at 2.80Å resolution |
1KTL |
HLA-E*01:03 binding "VTAPRTLLL" at 3.10Å resolution |
1 2
This work is licensed under a Creative Commons Attribution 4.0 International License.